We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Revealing Early Stages of Alzheimer's Disease with MRI

By MedImaging International staff writers
Posted on 18 May 2010
A major Australian study has provided new clues into the loss of structure in areas of the brain and its potential association with Alzheimer's disease (AD). These findings suggest an accumulation of deposits of the protein amyloid-beta in a region of the brain known as the temporal inferior cortex. The region is connected to the hippocampus, which is involved in memory.

AD is characterized by two factors: a build-up of amyloid-beta plaques in the brain, and a loss of neurons. The Commonwealth Scientific and Industrial Research Organization's (CSIRO; Victoria, Australia) Preventative Health flagship theme ;leader, Dr. Cassandra Szoeke, reported the mystery for researchers was that the parts of the brain that had shrunk (atrophied) due to neuron loss were not the same as those showing increased deposits of amyloid-beta.

Using magnetic resonance imaging (MRI) scans to assess Alzheimer's disease-affected brain tissue, the researchers discovered that shrinking (atrophy) of the hippocampus was associated with plaque deposits in the temporal inferior cortex. The study's findings indicate that the increased accumulation of amyloid in the temporal inferior cortex disrupts connections with the hippocampus, causing the neurons to die. "By helping to better understand the mechanisms involved in the progression of the disease, the study may guide the development of new strategies for early diagnosis,” Dr Szoeke said.

The study involved advanced techniques for analyzing and comparing different types of brain scans. Lead researcher was Dr. Perrick Bourgeat, from the Australian e-Health Research Center (Queensland, Australia)--a joint venture between CSIRO and the Queensland Government.

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) Study is being undertaken by CSIRO, the University of Melbourne, Edith Cowan University (Perth), Neurosciences Australia (Victoria), and the Mental Health Institute of Victoria.

The study's findings were reported in April 2010 issue of the journal Neurology.

Related Links:
Commonwealth Scientific and Industrial Research Organization
Australian e-Health Research Center

Digital X-Ray Detector Panel
Acuity G4
Portable Color Doppler Ultrasound System
S5000
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Digital Radiographic System
OMNERA 300M

Channels

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.